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Plasmodium falciparum is incapable of de novo purine biosyn-
thesis, and is absolutely dependent on transporters to salvage
purines from the environment. Only one low-affinity adenosine
transporter has been characterized to date. In the present study
we report a comprehensive study of purine nucleobase and
nucleoside transport by intraerythrocytic P. falciparum parasites.
Isolated trophozoites expressed (i) a high-affinity hypoxanthine
transporter with a secondary capacity for purine nucleosides,
(ii) a separate high-affinity transporter for adenine, (iii) a
low-affinity adenosine transporter, and (iv) a low-affinity/high-
capacity adenine carrier. Hypoxanthine was taken up with 12-
fold higher efficiency than adenosine. Using a parasite clone
with a disrupted PfNT1 (P. falciparum nucleoside transporter
1) gene we found that the high-affinity hypoxanthine/nucleoside
transport activity was completely abolished, whereas the low-
affinity adenosine transport activity was unchanged. Adenine
transport was increased, presumably to partly compensate for
the loss of the high-affinity hypoxanthine transporter. We thus
propose a model for purine salvage in P. falciparum, based on
the highly efficient uptake of hypoxanthine by PfNT1 and a high
capacity for purine nucleoside uptake by a lower affinity carrier.
Key words: drug target, equilibrative nucleoside transporter
family, nucleobase transporter, PfNT1, Plasmodium falciparum,
purine salvage.
INTRODUCTION
Plasmodium spp. are auxotrophic for purines, as are all other
parasitic protozoa studied to date, and require an efficient salvage
system for these essential nutrients [1]. Purine salvage may be
especially important during the fast dividing intraerythrocytic
stages, and it has long been known that Plasmodium trophozoites
accumulate some purines very rapidly [1,2]. Tracy and Sherman
[2] found that hypoxanthine, adenosine and inosine, but not aden-
ine or nucleotides, were efficiently taken up by the avian malaria
parasite P. lophurae. Similarly, the rodent malaria P. berghei was
reported to have two separate uptake systems for purines: one
for adenine and one for adenosine, inosine and hypoxanthine [3].
The study of purine metabolism in the human malaria species
P. falciparum, however, showed clearly that hypoxanthine was by
far the preferred purine source for the parasite, with very high
activities of hypoxanthine–guanine phosphoribosyltransferase
and inosine phosphorylase but not of adenine phosphoribosyl-
transferase or adenosine kinase [4]. Adenosine salvage appeared
to proceed through rapid deamination to inosine and thence to
hypoxanthine [4], and this process mostly occurs extracellularly
[5]. This explains the observation of Hansen et al. [3] that in-
hibition of adenosine deaminase with deoxycoformycin potently
reduced [3H]adenosine uptake by P. berghei. The resulting model
of a crucial role for hypoxanthine transport in Plasmodium purine
salvage was further validated by the study of Berman et al.
[6] who showed that depletion of hypoxanthine from infected
erythrocytes by xanthine oxidase reduced P. falciparum growth
by ∼90%.
Although hypoxanthine transport clearly plays a pivotal role in
an essential function of the malaria parasite, almost all available
information on Plasmodium purine transporters concerns uptake
of adenosine. Penny et al. [7] injected Xenopus oocytes with
mRNA from P. falciparum and observed increased uptake
of adenosine and hypoxanthine, sensitive to at least partial
reciprocal inhibition, demonstrating the presence of at least one
transporter capable of recognizing both substrates. Two groups
have independently cloned the same P. falciparum gene of the
ENT (equilibrative nucleoside transporter) family, which they
termed PfENT1 (P. falciparum ENT1) or PfNT1 (P. falciparum
nucleoside transporter 1) respectively [8,9], and the PfNT1 protein
was found to be localized in the plasma membrane of the
parasite [10]. Both groups expressed the cloned transporter in
Xenopus oocytes for characterization, but they arrived at strikingly
different conclusions. Carter et al. [9] described PfNT1 as a broad-
specificity nucleoside transporter of moderately high affinity
for adenosine and inosine and no affinity for nucleobases. In
contrast, Parker et al. [8] report a purine nucleoside/nucleobase
transporter with a similar, but low, affinity for adenosine, adenine
and hypoxanthine. The presence of a low-affinity adenosine
transporter was recently confirmed by Downie et al. [11] using
P. falciparum trophozoites isolated after treatment with saponin.
On the basis of the adenosine Km value, they concluded that
this activity must be PfNT1, and this seemed to be confirmed
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by expression of PfNT1 in oocytes, which revealed a low-
affinity nucleoside transporter. However, in the present study
we will demonstrate conclusively that the low-affinity adenosine
transporter is not encoded by PfNT1.
Studies to date have not investigated the possibility of
a very high-affinity purine transporter, such as found in
other intracellular [12–14] and extracellular [15,16] protozoan
parasites. However, a recent report [17] did strongly suggest that
PfNT1 must encode a high-affinity purine transporter, as wild-type
P. falciparum were able to grow in very low levels of purines,
but PfNT1 parasites grew only in >10 μM hypoxanthine,
adenosine or inosine. The same study also showed that, at 1 μM
concentrations, accumulation of those three purines was reduced
in PfNT1, but the characteristics of this transporter in terms of
substrate affinity and specificity were not further investigated.
In the present study we report the first systematic study
of high-affinity hypoxanthine, adenine and adenosine transport
activities in P. falciparum trophozoites. We have identified
and characterized a broad-specificity carrier that transports
hypoxanthine, guanine, adenosine, guanosine and inosine,
but not adenine. In addition we characterized a low-affinity
adenosine transporter [denoted PfLAAT (P. falciparum low-
affinity adenosine transporter)] and a high-affinity adenine
transporter [denoted PfADET1 (P. falciparum adenine transporter
1)] and demonstrate the existence of a further low-affinity uptake
route for adenine (PfADET2). To confirm our hypothesis that
the high-affinity transport activity is encoded by the previously
reported PfNT1, we generated a mutant parasite clone with a
disrupted PfNT1 gene, designated pfnt1GU to distinguish itself
from the clone generated by El Bissati et al. [17]. pfnt1GU had
completely lost both the high-affinity adenosine-uptake capacity
and over 85% of hypoxanthine uptake, whereas low-affinity
adenosine uptake was unchanged and high-affinity adenine uptake
was slightly increased. We therefore conclude that PfNT1 encodes
a high-affinity hypoxanthine/purine nucleoside transporter.
In the present study we show for the first time a comprehensive
model of purine uptake by P. falciparum, in which the
intraerthrocytic stages express at least four distinct purine
transport activities. This model finally identifies the biochemical
and genetic basis for the overwhelming reliance of the parasite
on hypoxanthine salvage as its main purine source and is in line
with a recent analysis of the P. falciparum permeome that showed
the presence of four genes of the ENT family in its genome [18].
This family includes all protozoan purine transporters known to
date [1].
EXPERIMENTAL
Plasmodium lines, human cells and chemicals
All transport experiments were performed with the standard
3D7 drug-sensitive laboratory clone of P. falciparum, originally
obtained from David Walliker (School of Biological Sciences,
University of Edinburgh, Edinburgh, Scotland, U.K.). Human
blood and serum used for Plasmodium culture were obtained
from the Glasgow and West of Scotland Blood Transfusion
Service. Standard chemicals, including purines and pyrimidines,
were obtained from Sigma and of the highest purity avail-
able. The purine analogues JA-23 (2-amino-N6-amino-N6-
methyladenosine), JA-24 (2-amino-N6-amino-adenosine) and JA-
32 (N6-hydroxy-9H-purin-6-amine) were donated by Daniel
Brown and David Loakes (MRC Laboratory of Molecular
Biology, Cambridge, U.K.).
Culturing of P. falciparum for transport assays
Asexual parasites of P. falciparum were maintained in continuous
culture using slightly modified standard methods [19]. Briefly,
parasites were grown in RPMI 1640 medium supplemented
with 5.94 g/l Hepes, 0.21% NaHCO3 and 10% heat-inactivated
normal human serum at 5% haematocrit. The culture was
incubated at 37 ◦C under a gas mixture of 1% O2, 3% CO2
and 96%N2, and medium was changed daily. Parasitaemia of the
culture was routinely maintained below 5%, unless otherwise
stated. Prior to use in experiments, parasite cultures were
synchronized using a previously described method [20]. Transport
experiments were performed with cultures of parasitaemia
between 7 and 10% in order to maximize yield.
Saponin permeabilization of P. falciparum-infected erythrocytes
Permeabilized P. falciparum-infected erythrocytes were prepared
by incubating parasitized red blood cells with 0.15% (w/v)
saponin as described previously [21]. Briefly, the culture was
centrifuged at 600 g and the supernatant was removed. The cell
pellets were re-suspended in 5 vol of 0.15% (w/v) saponin
in PBS (137 mM NaCl, 27 mM KCl, 1.76 mM K2HPO4 and
8 mM Na2HPO4) for 1 min. The freed parasites were washed
three times with purine-free RPMI 1640 culture medium without
serum, and resuspended in the same medium. Parasitaemia was
determined by microscopical examination of thin blood smears
stained with Giemsa’s stain, and red-cell density was estimated
using a Neubauer counting chamber.
Transport assays with saponin-permeabilized Plasmodium
falciparum-infected erythrocytes
Transport assays were performed with synchronized cultures in
the trophozoite stage. After permeabilization of the erythrocytes
with saponin [22], which leaves the parasite plasma membrane
intact [23,24], the cells were resuspended in purine-free
RPMI 1640 at a concentration of 5 × 108 cells/ml. Uptake of
[3H]hypoxanthine (31 Ci/mmol; GE Healthcare), [3H]adenosine
(16.0 Ci/mmol; GE Healthcare) or [3H]adenine (32.2 Ci/mmol;
PerkinElmer) by P. falciparum trophozoites was measured using
a rapid stop/spin method essentially as described previously for
Trypanosoma brucei [25], Leishmania spp. [14,26], Toxoplasma
gondii [13] and human erythrocytes [27]. Transport was measured
either at various time intervals to generate plots of the uptake rate
against time, or over fixed time intervals in the presence of variable
inhibitor concentrations to generate plots for the determination
of Km and K i values, using non-linear regression (GraphPad
Prism version 4). Briefly, equal volumes of a suspension of
permeabilized-infected erythrocytes and a radiolabelled permeant
at twice its final concentration (as well as inhibitor at 2 ×
concentration, where applicable) were mixed for a predetermined
time. The influx of permeant into the cells was terminated by
adding 1 ml of ice-cold stop solution (unlabelled permeant at
saturating concentrations) and immediately pelleting the cells
by centrifugation at 13000 g in a microfuge through an oil-
mix [300 μl of five parts dibutylphthalate (Aldrich)/four parts
dioctylphthalate (Aldrich), v/v], thus preventing further uptake
of permeant, which remains in the aqueous layer. Non-mediated
influx of the respective permeant was assessed by determining
the rate of uptake of the radiolabelled permeant in the presence
of a saturating concentration of unlabelled permeant at both room
temperature (22 ◦C) and 0 ◦C.
The parasite pellets were processed after uptake using the
method previously described by Saliba et al. [28], with a slight
modification. The aqueous phase was removed by aspiration
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and the inside walls of the tube were carefully washed with
distilled water. The water was aspirated out, followed by the oil-
mix, and the inside of the tube wiped with folded tissue paper.
The cells were resuspended in 200 μl of 1% (v/v) Triton X-
100 in water for 10 min at room temperature, and proteins were
precipitated with 200 μl of 5% TCA (trichloroacetic acid). The
mixture was finally centrifuged for 7 min at 13000 g, and
the supernatant transferred into a scintillation vial and mixed
with 3.5 ml of scintillation fluid (OptiPhase HiSafe; PerkinElmer).
Radioactivity was determined with a PerkinElmer 1450 Microbeta
Wallac Trilux liquid scintillation counter. All uptake experiments
were performed in triplicate.
For any given permeant, the linear phase of uptake was first
determined with a constant permeant concentration incubated for
various times to generate a plot of uptake against time. Linearity
was assessed using linear regression and defined as a correlation
coefficient >0.95 and a significant difference from zero uptake
(F-test; GraphPad Prism version 4). When uptake was too rapid
to obtain linearity of transport at room temperature, this was
reassessed at 6 ◦C using a ThermoStat plus machine (Eppendorf),
as indicated in the Results and discussion section. Inhibition
studies were always performed well within the linear phase of
uptake, and thus reflect true initial rates of transport across the
P. falciparum plasma membrane rather than rates of metabolism
or sequestration.
Generation of P. falciparum clones with disrupted PfNT1
Our strategy for knocking-out the Plasmodium gene PfNT1
relies on single crossover homologous recombination and full
details of the methods are provided in the Supplementary data
(at http://www.BiochemJ.org/bj/411/bj4110287add.htm). Briefly,
a plasmid was constructed containing the central sequence
of PfNT1 spanning the predicted transmembrane domains
3–6 and part of transmembrane domain 2. The construct
was used to transfect P. falciparum parasites of clone 3D7
using standard methods [29], with control parasites treated
similarly but with no construct present during electroporation.
Transformed parasites were selected with blasticidin and cloned.
Successful disruption of the gene was confirmed using PCR and
Southern blot analysis as described in Supplementary data (at
http://www.BiochemJ.org/bj/411/bj4110287add.htm).
RESULTS AND DISCUSSION
High-affinity hypoxanthine transport in P. falciparum trophozoites
In order to study the transporters in the plasma membrane of
P. falciparum, infected human erythrocytes were permeabilized
with saponin, after which the erythrocyte plasma membrane
ceases to be a barrier to the passage of solutes [22] but
the parasite membranes are not significantly affected by this
saponin treatment protocol [23,24]. The parasitophorous vacuole
membrane remains, but this membrane is intrinsically permeable
to small solutes [30]. Therefore, initial rates of transport
measured in this system reflect uptake by the Plasmodium-
encoded transporters located in the plasma membrane of the
parasite.
Uptake of 0.25 μM or 0.1 μM [3H]hypoxanthine followed
a hyperbolical curve, which was linear for up to 120 s at
20 ◦C, with a rate of 0.62 +− 0.04 and 0.40 +− 0.03 pmol · (107
cells)−1 · s−1 respectively, and was completely inhibited by 1 mM
hypoxanthine (Figure 1A). The hypoxanthine thus accumulated
would, in the absence of metabolism, reach very high intracellular
concentrations: based on an intracellular volume of 2.8 × 10−7
Figure 1 Hypoxanthine transport in saponin-isolated P. falciparum
trophozoites
(A) Uptake of 0.25 μM [3H]hypoxanthine (squares) and 0.10 μM [3H]hypoxanthine (circles) into
saponin-permeabilized P. falciparum-infected erythrocytes in the presence (open symbols) or
absence (filled symbols) of 1 mM unlabelled hypoxanthine at 20◦C. The correlation coefficients
(r2) were determined as 0.99 and 0.98 for 0.25 μM and 0.1 μM radiolabel respectively, by
linear regression over the first 120 s. (B) Uptake of 30 nM [3H]hypoxanthine in the presence
or absence of various concentrations of unlabelled hypoxanthine (), adenosine () or JA32
(). Uptake rates are presented as the percentage of no-inhibitor controls and combined from
two experiments with 100 % values of 0.013 (adenosine and JA32) and 0.033 pmol · (107
cells)−1 · s−1 (hypoxanthine) respectively. Inset: conversion of hypoxanthine inhibition data
into a Michaelis–Menten plot for determination of K m and V max. Representative experiments are
shown, conducted in triplicate. Values are means +− S.E.M.
l/107 parasites isolated by saponin treatment [28], uptake of
0.25 μM hypoxanthine would be over 1000-fold concentrated
in the parasite, reaching a level of 260 μM in 2 min. Transport
rates remained constant during this time (i.e. linear phase of up-
take) because the rate of metabolism was greater than the rate of
transport, making transport the rate-limiting step. Alternatively,
high-affinity purine transport in P. falciparum may be energy-
dependent, as it is in other protozoan species [16,25,31], allowing
uptake against a concentration gradient, but this possibility was
not further investigated in the present study.
Determining [3H]hypoxanthine transport at sub-micromolar
concentrations revealed a very high-affinity transporter for
oxopurines, with a mean Km value for hypoxanthine of 0.34 +−
0.05 μM (n=6; Figure 1B, inset), a Vmax of 0.36+−0.12 pmol · (107
cells)−1 · s−1 (n = 6) and a mean K i value of 0.11 +− 0.01 μM
for guanine (n = 3). In addition, the nucleosides adenosine
(Figure 1B), inosine and guanosine displayed affinity in the low
micromolar range (Table 1). This hypoxanthine transporter with a
high affinity for purine nucleosides was designated PfNT1 based
c© The Authors Journal compilation c© 2008 Biochemical Society
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Table 1 Profile of purine transport in P. falciparum trophozoites
Values in bold are K m values obtained with radiolabelled substrate; other values are K i values obtained from dose-dependent inhibition of radiolabelled substrate. All values were determined using
non-linear regression from experiments in duplicate or triplicate with a minimum of eight points over the relevant range. Zero values were taken to be radiolabel associated with the cell pellet in the
presence of saturating concentrations of unlabelled permeant. aUnits for V max are pmol · (107 cells)−1 · s−1. ND, not determined.
High-affinity [3H]- High-affinity [3H]- Low-affinity [3H]- High-affinity [3H]-
hypoxanthine uptake (PfNT1) adenosine uptake (PfNT1) adenosine uptake (PfLAAT) adenine uptake (PfADET1)
K i or K m value K i or K m value K i or K m value K i or K m value
(at 22◦C; μM, +− S.E.M.) n (at 22◦C; μM, +− S.E.M.) n (at 6◦C; μM, +− S.E.M.) n (at 22◦C; μM, +− S.E.M.) n
V maxa 0.36 +− 0.12 6 0.18 +− 0.08 3 0.19 +− 0.03 3 0.0004 +− 0.0002 3
V max/K m 1.1 0.090 0.00096 0.0019
Hypoxanthine 0.34+− 0.05 6 0.75 +− 0.18 3 ND >1000 3
Guanine 0.11 +− 0.01 3 ND ND >50 3
Inosine 2.0 +− 0.2 3 ND ND >1000 3
Adenosine 4.0 +− 0.67 3 2.0+− 0.2 3 197+− 20 3 2.0 +− 0.2 3
Guanosine 11.6 +− 2.7 3 ND ND ND
Adenine >500 3 240 +− 70 3 ND 0.23+− 0.07 3
on our later observations linking the PfNT1 gene to this transport
activity (see below).
PfNT1 exhibited a low affinity for pyrimidines. Only
uridine, uracil and thymidine inhibited transport of 30 nM
[3H]hypoxanthine significantly at a concentration of 1 mM inhib-
itor, by 36 +− 9% (P < 0.05), 49 +− 6% (P < 0.01) and 57 +− 6%(P < 0.02) respectively (measured using a paired Student’s t test
against a no-inhibitor control; based on four independent
experiments in duplicate). Cytosine, thymine and cytidine (up
to 1 mM) did not significantly inhibit 30 nM [3H]hypoxanthine
transport (results not shown). This result is not surprising, in
the light of the well-documented inability of Plasmodium spp.
to salvage preformed pyrimidine nucleobases and nucleosides
[1,32].
Of all of the natural purines tested, only adenine had very
little effect on transport of 30 nM [3H]hypoxanthine, with less
than 50% inhibition at 1 mM. However, the antiplasmodial
adenine analogue JA-32 [33] displayed a K i value of 14 +− 3 μM(Figure 1B), probably as a result of its ‘hypoxanthine-like’
conformation (i.e. lactam hydrogen on N1 and hydrogen-bond
acceptor at the N6 position; see Figure 1B). Two N6-sub-
stituted adenosine analogues, JA-23 and JA-24, with antiplas-
modial activities in the low micromolar range [33], had little
(K i = 320 +− 80 μM for JA-24) or no (JA23) effect on high-affinity
hypoxanthine transport (results not shown).
The transporter appeared to display a preference for oxopurine
nucleobases over aminopurine bases whereas this preference
appeared to be curiously absent in the binding of nucleosides:
e.g. guanine is the highest affinity nucleobase whereas guanosine
is the lowest affinity purine nucleoside (Table 1). Two testable
hypotheses may be proposed to explain this apparent paradox:
(i) the nucleosides are not actually substrates, but allosteric
inhibitors of hypoxanthine transport, or (ii) the nucleosides and
nucleobases assume a different orientation within the binding
pocket, due to the presence of the ribose moiety. In order to
distinguish between these alternatives, we assessed the uptake of
low concentrations of [3H]adenosine.
High-affinity adenosine transport in P. falciparum trophozoites
Uptake of 0.25 μM [3H]adenosine proceeded with a rate of
0.015 +− 0.002 pmol · (107 cells)−1 · s−1 over the linear phase (at
least 30 s), and was completely inhibited by 1 mM adenosine
(see Supplementary Figure S1 at http://www.BiochemJ.org/
bj/411/bj4110287add.htm). At the end of the linear phase, cells
Figure 2 Uptake of low concentrations of [3H]adenosine in isolated
P. falciparum trophozoites
Transport of 0.25 μM [3H]adenosine was measured over 30 s in the presence or absence of
various concentrations of unlabelled adenosine (), adenine (H17009) and hypoxanthine (). Inset:
conversion of the adenosine inhibition data into a Michaelis–Menten plot. The adenine IC50
value was obtained by extrapolation to 100 % inhibition. Representative experiments performed
in triplicate are shown. Values are means +− S.E.M.
had transported approx. 0.55 pmol of [3H]adenosine/107 cells,
which would correspond to ∼8-fold the extracellular con-
centration if unmetabolized. Both the rate of uptake and the
level of concentration of adenosine were much less than for
hypoxanthine.
Uptake of 0.25 μM [3H]adenosine was potently inhibited by
hypoxanthine (mean K i = 0.75 +− 0.18 μM; n = 3) and unlabelled
adenosine, but only by very high concentrations of adenine
(Figure 2). Over three separate experiments, the average of
the extrapolated values for an adenine IC50 value would be
∼1 mM, three orders of magnitude lower affinity than for hypox-
anthine. In the same three experiments, the inhibition by
hypoxanthine was not quite complete at 100 μM (6.1 +− 0.2%;
P < 0.05, paired Student’s t test), possibly the result of a minor
contribution to 0.25 μM [3H]adenosine flux from a second, low-
affinity adenosine transporter, that is insensitive to hypoxanthine
(see below). The mean Km for adenosine on the high-affinity
transporter was determined to be 2.0 +− 0.2 μM and the Vmax
as 0.18 +− 0.08 pmol · (107 cells)−1 · s−1 (n = 3; Figure 2, inset).
The strikingly similar reciprocal Km and K i values for adenosine
and hypoxanthine uptake are consistent with high-affinity uptake
c© The Authors Journal compilation c© 2008 Biochemical Society
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of both hypoxanthine and adenosine by PfNT1. However, the
Vmax/Km ratio indicates an 11.9-fold higher efficiency of trans-
location for hypoxanthine compared with adenosine, consistent
with the preference for hypoxanthine for optimal growth
in vitro.
The different selectivity for aminopurine nucleobases and
nucleosides noted in the previous section thus seems to indicate
that nucleobases and nucleosides orient differently in the same
binding site and the kinetic profiles shown in the present study
are consistent with competitive inhibition (Figures 1B and 2).
There are precedents for this; for instance, there is good evidence
for different binding orientations for xanthine and uric acid in the
Aspergillus nidulans UapA purine transporter [34].
Uptake of [3H]adenine is mediated by a separate high-affinity
transporter
At 1 μM [3H]adenine, uptake was 0.0091 +− 0.0025 pmol · (107
cells)−1 · s−1 over the linear phase (6 s; r2 = 0.93) and mostly
inhibited by 1 mM unlabelled adenine (results not shown). At
120 s the accumulation ratio (intracellular/extracellular radiolabel
concentration based on the intracellular volume of 2.8 × 10−7
l/107 parasites cited above) had reached ∼0.6, consistent with an
equilibrative process and at best a slow rate of metabolism or no
metabolism at all. We tentatively designate this novel transport
activity PfADET1, pending the identification of the encoding
gene.
In order to determine the Km value for this high-affinity
transporter, uptake of adenine was assessed at 50 nM of radiolabel.
Uptake was linear and did not reach equilibrium for up to 240 s
(the accumulation ratio was 0.65) (Figure 3A). This allowed
inhibition experiments at an incubation time of 150 s, although it
was clear that there was a small uptake component that was not
sensitive to 1 mM adenine (Figure 3A), possibly resulting from
the presence of a very low-affinity transporter. Adenine transport
was not inhibited by the oxopurines hypoxanthine, guanine and
inosine (results not shown), though it was sensitive to adenosine,
with a K i value of 2.0 +− 0.2 μM (Figure 3B).The sub-micromolar
Km value, similar to the hypoxanthine Km for PfNT1, and very
low Vmax (Figure 3B), make PfADET1 a high-affinity but low-
capacity transport system with a maximum uptake rate 2–3 orders
of magnitude lower than that measured for high-affinity transport
of hypoxanthine and adenosine (Table 1).
A very low-affinity/high-capacity transporter of adenine
As the uptake of 0.05 μM [3H]adenine was consistently not
fully inhibited by 1 mM unlabelled adenine (see above), we
investigated the possible presence of a low-affinity adenine
transport activity in saponin-isolated P. falciparum trophozoites.
Uptake of 10 μM [3H]adenine was linear for up to 12 s, with a
rate of 0.13 +− 0.01 pmol · (107 cells)−1 · s−1 (r2 = 0.96), reaching
an accumulation ratio of 0.85 in 30 s. This could not be
entirely attributed to simple diffusion as it was partly inhibited
(∼60%) by 1 mM adenine (Supplementary Figure S2A at
http://www.BiochemJ.org/bj/411/bj4110287add.htm). Attempts
to establish a Km value for [3H]adenine uptake on this transporter
were unsuccessful, due in part to the high rate of diffusion
of adenine at high concentrations, as reported for the related
apicomplexan parasite Toxoplasma gondii [13], and because the
limitations of adenine solubility prevented the determination
of a complete inhibition curve (Supplementary Figure S2B at
http://www.BiochemJ.org/bj/411/bj4110287add.htm). However,
the Km for adenine was estimated to be approx. 1 mM, and the K i
value for adenosine >2.5 mM. There was no clear inhibition by
up to 1 mM hypoxanthine (results not shown). This observation,
Figure 3 Characterization of a high-affinity adenine transporter in
P. falciparum trophozoites
(A) Transport of 0.05 μM [3H]adenine over 240 s, in the presence () or absence
() of 1 mM unlabelled adenine. In the absence of inhibitor the transport rate was
3.9 +− 0.2 × 10−5 pmol · (107 cells)−1 · s−1 as calculated by linear regression (r2 = 0.98). At
240 s, uptake was inhibited 70 % by 1 mM adenine. (B) Transport of 0.05 μM [3H]adenine was
inhibited by increasing concentrations of unlabelled adenine () or adenosine (). Adenine
uptake was expressed as a percentage of the control because two different experiments were
combined, with no-inhibitor values of 2.4 × 10−4 and 1.5 × 10−4 pmol · (107 cells)−1 · s−1.
Inset: conversion of the inhibition data into a Michaelis–Menten plot, yielding a K m value
of 0.12 μM for this experiment. Units of uptake were pmol · (107 cells)−1 · s−1. Values are
means +− S.E.M.
and the fact that these experiments were carried out at 10 μM
[3H]adenine, which fully saturates PfADET1, as well as the low
affinity for adenosine, clearly shows that this adenine transport
phenomenon must be mediated by a low-affinity transporter
separate from either PfNT1 or PfADET1. The low-affinity adenine
transport activity was provisionally designated PfADET2.
Despite the presence of two adenine transporters, it is not at all
clear whether adenine salvage is important to Plasmodium spp.
and there is considerable controversy as to whether Plasmodium
can utilize adenine at all, as several groups report the inability
to identify genes encoding adenine phosphoribosyltransferase
and methylthioadenosine phosphorylase in any Plasmodium
species [35,36]; neither is there any evidence for the activity
of adenine deaminase [35]. Yet, the characterization of adenine
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phosphoribosyltransferase from P. chabaudi and P. falciparum
has been reported [37,38]. In addition, P. falciparum is reportedly
able to grow in vitro on adenine as the sole purine source [39] and
P. knowlesi incorporated adenine into nucleic acids [32]. Although
these latter observations could be explained by conversion of the
adenine into hypoxanthine in the host cell, Van Dyke [40] reported
that the free parasite can also incorporate adenine into nucleic
acids, albeit at 1% of the efficiency by which hypoxanthine
is incorporated. The results in the present study of uptake of
adenine by P. falciparum trophozoites, however inefficient, would
be compatible with the view that adenine can be utilized in some
way but is unlikely to play any major role in the synthesis of
nucleotides. It is conceivable that the parasite has a different use
for low levels of adenine, which it cannot generate itself from
other purines [35], or that adenine at high concentrations could
be deaminated by adenosine deaminase.
Low-affinity transport of [3H]adenosine in P. falciparum
trophozoites
Several groups have reported a much lower-affinity adenosine
transport process than the Km value reported in the present
study for PfNT1 [8,9,11]. We therefore decided to reinvestigate
the presence of such a transporter and found that 25 μM
[3H]adenosine is taken up extremely rapidly at room temperature
(see Supplementary Figure S3A at http://www.BiochemJ.org/bj/
411/bj4110287add.htm), as reported by Downie et al. [11],
reaching an accumulation ratio of ∼0.6 by 30 s. We therefore
conducted our experiments at 6 ◦C and consistently found that
uptake of 25 μM [3H]adenosine was linear over a period
of 4–6 s at this temperature (see Supplementary Figure S3B
at http://www.BiochemJ.org/bj/411/bj4110287add.htm), and that
initial rates of transport could therefore be assessed over a 3 s
interval. At 22 ◦C, 10 ◦C or 6 ◦C we found that transport was
saturable by 1 mM unlabelled adenosine, although this never
inhibited fully 100% of transport (Figure 4 and Supplementary
Figure S3), reflecting the low affinity of this transporter
for the substrate. At 6 ◦C the rate of uptake of 25 μM
[3H]adenosine was 0.041 +− 0.004 pmol · (107 cells)−1. The mean
Km value under these conditions was 197 +− 20 μM, with a Vmax
of 0.19 +− 0.03 pmol · (107 cells)−1 · s−1 (n = 3; Figure 4). This
transporter was not sensitive to the nucleoside transport inhibitor
dipyridamole at concentrations of up to 25 μM (results not
shown). We have designated this activity PfLAAT.
These observations are entirely consistent with the only
other characterization of adenosine transport in P. falciparum
trophozoites, by Downie et al. [11]. They reported a low-affinity
adenosine transporter that mediated uptake of adenosine, inosine
and thymidine very quickly, equilibrating within seconds, and
insensitive to dipyridamole.
Disruption of the PfNT1 gene
In order to gain insight into the possible role of PfNT1 in purine
salvage, a parasite line with a disrupted locus was generated.
Single crossover homologous recombination at the PfNT1 locus
was expected to generate a pseudodiploid configuration, with both
truncated copies lacking some of the transmembrane domains
of the protein predicted to be essential for the function of
the protein (Supplementary Figure S4 at http://www.BiochemJ.
org/bj/411/bj4110287add.htm). As the parasite is haploid and
PfNT1 is a single-copy gene, only one round of drug selection
is necessary to obtain a null-mutant. Four parasite clones,
denoted B11, D6, B7 and B9, were obtained, and successful
disruption of the PfNT1 gene was verified in each clone by
PCR and by Southern blot (Supplementary Figures S5 and
Figure 4 Low-affinity transport of adenosine in saponin-isolated
Plasmodium falciparum trophozoites
Transport of 25 μM [3H]adenosine was determined over a 3 s interval at 6◦C, in the presence
of various concentrations of unlabelled adenosine as indicated. Inset: conversion into a
Michaelis–Menten plot. Values are means +− S.E.M.
S6 at http://www.BiochemJ.org/bj/411/bj4110287add.htm). The
mutant PfNT1 clones were designated pfnt1GU, in order to
distinguish them from the independently derived pfnt1 clone
of El Bissati et al. [17].
Purine transport in the pfnt1GU clone
We next determined the purine uptake profile in the pfnt1GU
clone D6, using as controls untransformed parasites (wild-type)
that had undergone the same procedures. The transport assays
were performed simultaneously on both clones, to assess which,
if any, of the above identified purine transport activities was
affected in the parasites with the disrupted gene. Uptake of
25 μM [3H]adenosine at 6 ◦C was not affected by the disruption
of PfNT1, and identical rates of uptake were measured in the two
lines: 0.069 +− 0.05 and 0.070 +− 0.07 pmol · (107 cells)−1 · s−1 for
pfnt1GU and control respectively (Figure 5A).
In contrast, in several experiments, uptake of 0.25 μM
[3H]adenosine was reduced by 97–100% in pfnt1GU (n = 3;
Figure 5B), clearly indicating the loss of high-affinity transport in
the mutant line. Similarly, uptake of 0.4 μM [3H]hypoxanthine
over 120 s was reduced by 82–98% (n = 3; Figure 5C). The
small residual hypoxanthine transport leads us to speculate that
a low-affinity hypoxanthine activity might also be expressed in
P. falciparum. This would be consistent with the observation of
El Bissati et al. [17] that pfnt1 P. falciparum are able to grow
in the presence of high concentrations of hypoxanthine but not in
low concentrations.
Transport rates of 1 μM [3H]adenine were not affected in the
PfNT1 parasites: the initial rates of transport over 12 s were
not significantly different in the pfnt1GU line and control cells
(n = 3; paired Student’s t test, P > 0.05) (Figure 5D and inset).
However, in three independent experiments the maximum level
of [3H]adenine transport in the pfnt1GU line was double that of
the control [0.16 +− 0.06 compared with 0.077 +− 0.022 pmol · (107
cells)−1 · s−1; n = 3, non-linear regression]. Rather than up-
regulation of the transporter we believe this may reflect an
increased rate of adenine metabolism in the absence of a source
for hypoxanthine.
The clear conclusion from these results is that PfNT1
encodes the high-affinity hypoxanthine/adenosine transporter.
This conclusion is somewhat at odds with the reports of
PfNT1 as a relatively low-affinity transporter when expressed in
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Figure 5 Purine transport in P. falciparum trophozoites lacking PfNT1
Transport in pfnt1GU is indicated with  and in control 3D7 parasites with . (A) [3H]Adenosine (25 μM) at 6◦C. (B) [3H]Adenosine (0.25 μM) at 22◦C. (C) [3H]Hypoxanthine (0.4 μM) at
22◦C. (D) [3H]Adenine (1 μM) at 22◦C. Insets display the linear phase of uptake (r2 = 0.99 for pfnt1GU and 0.98 for control 3D7).
Xenopus laevis oocytes [8,9,11]. However, these previous reports
differ substantially from each other, producing adenosine Km
values of 320 μM, 13.2 μM and 1.86 mM respectively. It may be
that the Xenopus expression system produces ambiguous results
when expressing some Plasmodium transporters, possibly as a
result of the extremely high A+T content of the P. falciparum
genome [41] (PfNT1 is 72% A+T). This would also explain the
reported difficulties of expressing other P. falciparum ENT genes
in this system [11]. Also, the Carter et al. [9] study used a different
parasite clone from the Parker et al. [8] and Downie et al. [11]
studies (W2 and 3D7 respectively), which had a single amino
acid difference in their PfNT1 gene (leucine or phenylalanine
respectively at position 385). This could perhaps explain some
of the discrepancy, especially since the Phe385 polymorphism is
unusual: in a multiple alignment of 28 protozoan ENT family
genes plus the four human ENT sequences, the equivalent amino
acid residue was conserved in so far as it was never aromatic,
amide, charged, cysteine or proline. However, it is unlikely that
the 3D7 clone of P. falciparum encodes a partly deficient PfNT1,
as this clone was also used in the study reported by El Bissati et al.
[17] that first suggested that PfNT1 is essential for growth on low
purine concentrations. We also used the 3D7 clone in the present
study and verified that its PfNT1 sequence was 100% identical
with the entry in PlasmoDB (PF13_0252) and with the sequence
reported by Parker et al. [8].
A new model for purine salvage by P. falciparum
The results of the present study, establishing a central role for
a high-affinity hypoxanthine transporter in the purine salvage of
P. falciparum, agree very well with the early studies of purine
salvage in other Plasmodium species, which describe a transport
system for hypoxanthine with a secondary capacity for purine
nucleosides and a separate uptake system for adenine [1]. It is also
consistent with the current understanding that purine nucleotide
synthesis in Plasmodium spp. is overwhelmingly through
phosphoribosylation of nucleobases, particularly hypoxanthine,
rather than nucleoside kinases [4,5,42] and they do not seem to
encode an adenosine kinase in their genome [35,36]. Furthermore,
it brings purine uptake in P. falciparum very close to purine
transport activities reported for other protozoa, which typically
display Km values in the 0.2–5 μM range for their substrates
[1]. Earlier proposals that P. falciparum may rely exclusively on
low-affinity purine transporters seemed hard to reconcile with a
free concentration of purine nucleosides and bases in the infected
erythrocyte that is presumably at best in the low micromolar range.
Both the hENT1 nucleoside [43] and hFNT1 (human facilitative
nucleoside transporter 1) nucleobase [27] transporters of human
erythrocytes are equilibrative, making it impossible for the free
concentrations of substrates to exceed those in plasma. Nor is it
likely that purine concentrations are much higher at the parasite
plasma membrane, as the parasitophorous vacuole membrane is
freely permeable to such low-molecular-mass solutes [30].
However, at adenosine concentrations that saturate the high-
affinity PfNT1 transporter, a very rapid and saturable nucleoside
transport activity, PfLAAT, was observed. Our transport
experiments with pfnt1GU prove that this is indeed a separate
transporter from PfNT1. We conclude that P. falciparum troph-
ozoites express both a high-affinity purine nucleobase/nucleo-
side transporter and a low-affinity/high-capacity adenosine
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Figure 6 Model of purine uptake into intraerythrocytic P. falciparum trophozoites
Double-headed arrows indicate presumed equilibrative transport, whereas the single-headed arrow of PfNT1 indicates possible active transport. However, the assignment of active or equilibrative
transport is speculative and was not investigated in the present study. hFNT1 and hENT1 are endogenous to the human erythrocyte whereas the origin of the NPP (new permeation pathways) is
unknown. The thickness of arrows for the P. falciparum transporters is meant to convey the relative flux of purines. IEC, infected erythrocyte cytoplasm; PV, parasitophorous vacuole.
transporter in addition to a saturable transport system for
[3H]adenine. The Km value of ∼200 μM for PfLAAT rules out
the possibility that it might be identical with the high-affinity
adenine transporter PfADET1 [K i(adenosine) = 2.0 μM] and
equally appears to rule out that it is identical with the low-affinity
adenine transport activity PfADET2 that is almost insensitive to
adenosine. However, this awaits proof, consisting of experiments
with genetic deletion lines of the genes encoding these purine
transporters (which are currently in progress).
Thus a model arises (shown in Figure 6) that closely mirrors the
model for purine transport in the only other apicomplexan parasite
for which purine transport has been studied in detail. Toxoplasma
gondii is known to express a low-affinity adenosine transporter
TgAT1, with a Km value of ∼110 μM [13,44,45], as well as a
high-affinity transporter TgAT2 (Km is 0.49 μM for adenosine
and 0.77 μM for inosine) [13]. The main difference between
purine salvage in the two apicomplexan species is that, unlike P.
falciparum, T. gondii expresses separate high-affinity transporters
for purine nucleosides (TgAT2) and oxopurine nucleobases
(TgNBT1). Like PfNT1, TgNBT1 does not transport adenine [13].
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